![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 43, 40260-40264, October 25, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110
Received for publication, June 20, 2002, and in revised form, August 2, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Highly conserved amino acids that form crucial
structural elements of the catalytic apparatus can be used to account
for the evolutionary history of serine proteases and the cascades into which they are organized. One such evolutionary marker in
chymotrypsin-like proteases is Ser214, located
adjacent to the active site and forming part of the primary specificity
pocket. Here we report the mutation of Ser214 in thrombin
to Ala, Thr, Cys, Asp, Glu, and Lys. None of the mutants seriously
compromises active site catalytic function as measured by the kinetic
parameter kcat. However, the least conservative mutations result in large increases in Km because
of lower rates of substrate diffusion into the active site. Therefore, the role of Ser214 is to promote the productive formation
of the enzyme-substrate complex. The S214C mutant is catalytically
inactive, which suggests that during evolution the TCN Serine proteases have been classified into evolutionarily and
structurally unrelated clans (1), which nevertheless maintain a
strictly conserved active site geometry among their catalytic Ser, His,
and Asp residues. This shared catalytic structure suggests that common
architectural motifs can be found in the molecular design of active
sites utilizing a Ser-His-Asp triad. The identification of discrete
evolutionary markers encountered in the sequences contributing to the
catalytic apparatus has shed light on both crucial structural motifs
and evolutionary events in the history of serine protease families (2)
and serine protease cascades (3). One such structural motif common to
chymotrypsin-like, subtilisin-like, and The role of Ser214 in chymotrypsin-like proteases has been
addressed in previous studies (5). The trypsin mutants S214E and S214K
disrupted the environment of the catalytic Asp102 as
demonstrated kinetically and crystallographically. However, the S214A
mutant described in the same report had improved specificity (kcat/Km) compared with wild
type, calling into question the requirement for the Ser214
side chain in catalysis. More importantly, previous studies on trypsin
have not addressed how mutations of Ser214 affect the
individual steps of the catalytic mechanism of substrate hydrolysis and
have left the precise origin of the perturbation unanswered.
Here we report the effect of several substitutions (Ala, Asp, Glu, Lys,
Thr, and Cys) of Ser214 in thrombin by dissecting the
kinetics of substrate hydrolysis using a novel and powerful approach
(10). Considering the TCN Site-directed mutagenesis of human The substrate H-D-Phe-Pro-Arg-p-nitroanilide
(FPR) was synthesized by Midwest Biotech (Carmel, IN). Individual rate
constants defining the mechanism of substrate hydrolysis by serine
proteases were extracted from the values of kcat
and kcat/Km obtained as a
function of temperature (10) from 5 to 45 °C under solution conditions of 5 mM Tris, 0.1% PEG-8000, 200 mM
NaCl, pH 8.0. The values for the Na+-free slow form of wild
type were obtained by replacing NaCl with ChCl in the buffer. Substrate
hydrolysis entails the binding of substrate S to the enzyme E with a
second-order rate constant k1. After the
formation of the enzyme-substrate complex ES, the substrate can either
dissociate back into the solution with a rate constant of
k
AGY codon
transitions for Ser214 occurred through Thr intermediates.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
/
-hydrolase-fold serine
proteases is the presence of a highly conserved fourth active site
residue whose backbone atoms form contacts with the substrate and whose
polar side chain extends into the catalytic pocket. Among
chymotrypsin-like proteases, the backbone of Ser214
contributes to the S1 binding pocket (4). The side chain of the same
residue is hypothesized to generate a polar environment for the
catalytic Asp102 of trypsin (5), and both oxygens of
Ser214 form H-bonds with waters located in the active site
cleft of duodenase (6). Ser125 (subtilisin BPN' numbering)
in subtilisin-type proteases (4, 7) and the unpaired Cys341
(yeast carboxypeptidase W numbering) in
/
-hydrolase-fold
proteases (8, 9) play similar roles. Each of these residues
(Ser214, Ser125, and Cys341) serves
as an evolutionary marker and appears to contribute to catalytic
function in its respective protease clan (2).
AGY Ser codon transitions that must have
taken place at Ser214 (2), it has now become relevant to
also generate S214T and S214C mutants as the codons for Thr and Cys
(ACN and TGY, respectively) represent intermediates in the single
nucleotide transitions between TCN and AGY. In addition to trypsin,
thrombin is a most relevant system for studying the contribution of
Ser214 to serine protease catalysis. Thrombin is a
Na+-activated enzyme, which adds complexity to the
mechanism of substrate recognition, and has a more stringent
specificity profile than trypsin that may be more sensitive to
mutations that alter kcat or
Km. Hence, the mutation of Ser214 in
thrombin would reveal whether that evolutionary marker is linked to
Na+ binding in serine proteases and would test whether
previous results on trypsin can be generalized to the majority of
chymotrypsin-like proteases.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-thrombin was carried out
in a HPC4-pNUT expression vector using the QuikChange site-directed mutagenesis kit from Stratagene (La Jolla, CA). Expression of thrombin
mutants was carried out in baby hamster kidney cells as described
previously (11). Mutants were activated with the prothrombinase complex
between 40 and 60 min at 37 °C. Enzymes used in the activation were
supplied by Enzyme Research (South Bend, IN). Mutants were purified to
homogeneity by fast protein liquid chromatography using Resource Q and
S columns with a linear gradient from 0.05 to 0.5 M choline
chloride (ChCl), 5 mM
MES,1 pH 6.0, at room
temperature. Active site concentrations were determined by titration
with hirudin.
1 or become acylated with a rate constant of
k2. The portion of substrate distal to the
scissile bond, P', is released at this stage. The acyl intermediate
EP is subsequently hydrolyzed to release the portion of
substrate proximal to the scissile bond, P", with a rate constant of
k3 as shown in Scheme 1.
The acylation step is typically rate-determining for amide
substrates. The Michaelis-Menten parameters s = kcat/Km and
kcat accessible to direct experimental
measurements are composite functions of the individual kinetic rates in
Scheme 1. The explicit expressions as a function of temperature are
shown in Equations 1 and 2 (10),
(Eq. 1)
(Eq. 2)
where Ej is the activation energy
associated with the rate constant kj,
R is the gas constant, T is the absolute
temperature, and the k values refer to
T0 = 298.15 K. The measurements of s and kcat as a function of temperature can
resolve all the parameters in Equations 1 and 2 provided the plots show
curvature. In the event of
k3
k2 (
1) as
typically observed for thrombin, k3 and E3 cannot be resolved and the plot of
logkcat versus 1/T is a straight line. When kcat values cannot be
determined because of high Km values, a plot of logs
versus 1/T yields k1, E1, the ratio
= k2/k
1, and the
difference E
=
E
1
E2, again
provided the plot shows curvature.
Physiologic substrates and inhibitors were studied under the conditions of 5 mM Tris, 0.1% PEG-8000, 200 mM NaCl, pH 8.0 at 25 °C. The cleavage of fibrinogen leading to the release of fibrinopeptides A and B and cleavage of the protease-activated receptor (PAR) peptides PAR1, PAR3, and PAR4 were carried out by HPLC as described previously (12). The activation of protein C in the presence of 5 mM CaCl2 and 10 nM rabbit thrombomodulin was measured and analyzed as reported elsewhere (11). Antithrombin inhibition was studied by changing the concentration of unfractionated heparin to determine the optimal inhibition of each mutant (13), monitored by following progress curves of FPR hydrolysis in which the antithrombin concentration was varied. The observed rate of inhibition, kon, was calculated as described previously (11).
Equilibrium dissociation constants for Na+ binding were
determined by fluorescence titration using a FluoroMax-3 SPEX
spectrophotometer. Fluorescence titrations took place under
experimental conditions of 5 mM Tris, 0.1% PEG-8000, 800 mM ionic strength, pH 8.0 at 10 °C. The temperature was
chosen to maximize both the intrinsic fluorescence of the enzyme and
the fluorescence increase induced by Na+ binding.
Titrations were carried out by adding aliquots of thrombin in 800 mM NaCl to a solution containing the enzyme in 800 mM ChCl. Ionic strength (800 mM) and enzyme
concentration (200 nM) were held constant, whereas
[Na+] was varied. Excitation was at 295 nm, and emission
was measured at 333 nm. The value of thrombin intrinsic fluorescence,
F, as a function of [Na+] was fit according to
the Equation 3,
|
(Eq. 3) |
Na+ dissociation constants were alternately determined by
following the linkage between the
kcat/Km for FPR hydrolysis and [Na+] under conditions of 50 mM Tris,
0.1% PEG-8000, pH 8.0 at 25 °C. The value of s = kcat/Km was fit according to the Equation 4 (11),
|
(Eq. 4) |
Temperature melting curves were measured under conditions of 200 mM NaCl or ChCl, 5 mM Tris, pH 8.0, 0.1%
PEG-8000 over the temperature range of 15-80 °C. Denaturation was
monitored by following absorbance at 280 nm. Experiments were conducted
using sufficient enzyme to generate an absorbance of ~0.05 absorbance
units at 15 °C. Temperature was then gradually increased to 80 °C
at a rate of 1.5 °C/min. The melting temperature was calculated from the midpoint of the melting transition.
| |
RESULTS |
|---|
|
|
|---|
Ser214 thrombin mutants have reduced catalytic activity as measured by FPR hydrolysis with the most significant reductions corresponding to the mutants carrying the largest side chains at position 214 (Table I). Although the Ala, Thr, and Lys mutants have reduced kcat compared with wild type, the Asp and Glu mutants have increased kcat. Therefore, changes in kcat do not correlate with the size of the side chain placed at position 214. However, the presence of a residue other than Ser at position 214 dramatically increases Km. The least conservative mutant, S214K, shows a 1000-fold increase in Km with only a 3-fold drop in kcat. Only limited kinetic data could be collected for the S214C mutant (see below).
|
The impact of Ser214 on Km rather than
kcat suggests a major role in substrate binding,
which is confirmed by the individual rate constants gleaned from
temperature dependence studies of kcat/Km and
kcat for FPR hydrolysis (Fig.
1 and Table I). The increases in
Km are primarily attributable to decreases in the
rate of association k1, which are most
significant for the least conservative mutations. The values of
k1 for the Ala and Thr mutants approach that of
the slow form of wild type, whereas those of the Asp, Glu, and Lys
mutants deviate more to the downside and underline more drastic
structural perturbations of the accessibility of the active site. The
reductions in k1 tend to be linked to
significant decreases in the activation energy, E1, for this step. This suggests that wild-type
thrombin undergoes an induced fit rearrangement on substrate binding
that cannot be duplicated fully in the Ser214 mutants. The
integrity of the Ser side chain ensures this structural change and
optimizes the productive collision of substrate with the active site.
When the catalytic rate constants are considered, all mutants are like
wild type in that
k3
k2 and the
logkcat versus 1/T plot is
linear. Interestingly, none of the mutants compromises kcat significantly, and the presence of a
negatively charged side chain at position 214 actually increases the
acylation rate and kcat relative to wild
type.
|
There is an apparent dichotomy in the functional behavior of the
mutants of Ser214, because they tend to behave like
the Na+-free slow form of wild type when the rate of
substrate diffusion into the active site is considered but mimic more
closely the Na+-bound fast form in their catalytic rate
constants. This finding suggests that Ser214 is
energetically linked to Na+ binding especially in the steps
that control substrate binding and formation of the enzyme-substrate
complex. This expectation is confirmed by the inspection of the
Na+ binding affinities of the Ser214 mutants as
measured directly by intrinsic fluorescence titration (Fig.
2) that are compromised to a significant
extent (up to 50-fold). Consistent with these findings, Na+
binding partially rescues the Ser214 mutants (Table
II) because the value of the
specificity constant s0 in the absence of
Na+ (slow form) is more compromised relative to wild type
than the value s1 obtained under saturating
[Na+] (fast form). This finding demonstrates that the
deleterious effect of replacing Ser214 is felt more on the
Na+-free slow form.
|
|
Ser214 thrombin mutants also demonstrate impaired cleavage of physiologic substrates (Table III). Specificity constants for the release of fibrinopeptides A and B, which measure the ability of thrombin to cleave fibrinogen to form a fibrin clot, are compromised to a similar degree. Protein C activation, an anticoagulant activity, is slightly less compromised with the exception of S214K. The cleavage of PAR peptides is reduced to a similar extent for PAR1, PAR3, and PAR4. Because of the severely impacted catalytic efficiency of the S214K mutant, specificity constants toward PAR3 and PAR4 could not be measured. The least conservative mutants show the greatest reduction in antithrombin inhibition as measured by the rate of inactivation kon. The mutants require slightly higher concentrations of heparin relative to wild type to ensure inhibition. The optimal heparin concentration for wild type is 0.5 USP units/ml, whereas the majority of the mutants require 1-2 USP units/ml heparin. Selected S2 and S3 specificity subsite mutants of thrombin also demonstrate increased requirements for heparin (13).
|
The S214C mutant could not be characterized extensively. During the first attempt at activation of S214C prethrombin-1, the mutant thrombin appeared to aggregate in solution. Despite this result, it was possible to purify a fraction of the mutant whose absorbance indicated a concentration of 700 nM. However, titration with hirudin indicated an active site concentration of ~30 nM. Thus, 96% of the activated material was functionally inactive. A subsequent activation using a lower prothrombin concentration prevented aggregation, but once again the titration of the purified fraction revealed that nearly all of the activated material was catalytically inactive. The loss of activity seen for S214C is puzzling. Polyacrylamide gel electrophoresis of aliquots from the activation reactions and purified fractions does not indicate proteolysis. As the unpaired Cys points into the active site and away from the surface of the of the enzyme, intermolecular disulfide bonding appears improbable. It is possible that the presence of the extra Cys at position 214 causes improper intramolecular disulfide bonds to form, resulting in an incorrectly folded enzyme.
Temperature denaturation experiments were used to assess the relative
stabilities of wild type, S214T, and S214C. The melting temperatures
for the S214C and S214T mutants are 10 and 5 °C, respectively, lower
than that for wild type (62 °C). The instability of S214C does not
result from impaired Na+ binding as wild type has the same
melting temperature in both NaCl (fast form) and ChCl (slow form)
solutions. Ser214 appears to be an important residue for
the folding of thrombin. The mutation to Thr slightly destabilizes the
fold, but providing a free disulfide at this position destabilizes the
fold enough to produce an inactive and presumably misfolded enzyme.
| |
DISCUSSION |
|---|
|
|
|---|
The results presented here on the role of Ser214 in serine proteases extend those reported previously in the case of trypsin (5) that have left several basic questions unanswered. In particular, previous studies have characterized the kinetic origin of the perturbations only in terms of kcat and Km. Our study has examined the effect of Ser214 mutations on each step of the catalytic mechanism of substrate hydrolysis and has identified the precise events in which Ser214 is involved, namely the optimization of substrate diffusion in the active site, the induced fit rearrangement of the enzyme-substrate complex, and the unanticipated energetic linkage with Na+ binding.
Ser214 is the only residue among the four with side chains
in the active site that is not required for proper function of the Ser-His-Asp charge relay system. As such, it presents an opportunity to
probe the environment of the active site around Asp102. The
active site is extremely tolerant to substitution at position 214 as
the presence of a buried Lys produces only a 3-fold reduction in
kcat. However, it should be noted that in
trypsin, the reduction in kcat was more
dramatic. In
-lytic protease, the mutation of Ser214 to
Ala brought about a 4900-fold reduction in specificity, but Epstein and
Abeles (14) surmise that the catalytic function remained intact.
Ser214 seems to play a minimal role in governing the catalytic rate reflected by the minor effects on kcat. Crystal structures of trypsin (5) and duodenase (6) have led to the hypothesis that Ser214 helps position Asp102 of the charge relay system for optimal catalysis. Slight reductions in kcat for S214A, S214T, and S214K lend support to this idea but prove that Ser214 is not essential for effective catalysis. Catalytically, the most interesting mutants are S214D and S214E, which display increases in kcat despite the potential introduction of an additional charge into the active site. The Asp and Glu side chains may repel Asp102, pushing it closer to His57 and therefore increasing the potency of the charge relay system.
The mutation of Ser214 primarily disturbs the S1 pocket as active site function (measured by kcat) does not appear to suffer from the energetic perturbation associated with Ser214 mutation. The decrease in k1 and the increase in Km would then be explained by displacement of the backbone atoms of residue 214, the carbonyl oxygen of which makes contact with substrate (4). Ser is the appropriate connector at position 214 that ties the very stable active site to the S1 pocket to maintain optimal contact with substrate and correct alignment of the catalytic register. For trypsin substitutions involving large side chains (S214E and S214K), steric clashes with the side chain of Trp215 occur. This results in the Trp side chain "flipping" and blocking access to the S2 and S3 specificity pockets (5) and may explain the extremely poor specificity of S214K mutants in both thrombin and trypsin.
In thrombin, Na+ binds in a water channel extending from
the surface of the enzyme through the S1 specificity pocket into the active site and containing >20 water molecules interconnected by a
hydrogen-bonding network that includes the protein (15). The positions
of these internal water molecules are highly conserved and well
ordered. Several of those water molecules are involved in
Na+ coordination, and the hydrogen bond connectivity of the
S1 pocket water channel is altered when Na+ binds,
accounting for the change in specificity associated with the
Na+-triggered slow
fast transition (16). Residues that
are linked to this water channel are thus energetically linked to
Na+, and the perturbation of such residues may affect
Na+ binding as well as specificity. As a result,
Na+ binding is extremely sensitive to the architecture of
the S1 pocket (16).
Ser214 is not involved in Na+ coordination, and its side chain extends away from the Na+ site and into the active site. In fact, the Na+ binding site of thrombin resides 15 Å from Ser214 at the opposite end of the S1 specificity pocket. However, residues that are thermodynamically linked to Na+ binding need not be located near the Na+ binding site. For example, the mutations of Trp60d and Trp215 located 17 and 10 Å away from the Na+ site practically abolish Na+ binding (17, 18). The backbone atoms of Trp215 adjacent to Ser214 make contact with two water molecules of the S1 channel (19), and perturbations of Ser214 may be transmitted via Trp215 to the four water ligands coordinating the Na+ ion (15, 16). The significantly reduced Na+ binding of Ser214 mutants indicates the long range influence of that residue on the S1 pocket structure. Also, the structural perturbation caused by the replacement of Ser214 affects predominantly the Na+-free slow form (Table II) and is corrected by Na+ binding by virtue of the reciprocity of the linkage between this residue and Na+ as seen for mutants of residues Trp60d and Trp215 (17, 18).
The S214C mutant is 95% inactive. The residue presumably engages in an
improper disulfide bond with another Cys residue; however, there is no
outstanding candidate for this other residue because the nearest Cys to
Ser214 is 9 Å away. Temperature denaturation studies also
suggest that Ser214 plays a role in thrombin stability.
Among
/
-hydrolase-fold serine proteases, the residue analogous to
Ser214 is frequently the unpaired Cys341. A
subtilisin-like protease with Cys at the analogous position 125 also
exists (2). Therefore, unpaired Cys residues are easily tolerated
adjacent to serine protease active sites except in the chymotrypsin-like clan. There are several instances of Thr usage at
position 214 including human complement factor D. In factor D, Thr and
Ser are interchangeable (20), indicating the viability of Thr at
position 214. The unsuitability of Cys and the feasibility of Thr at
position 214 of thrombin suggest the codon switch for Ser214 from TCN to AGY if occurring by single-nucleotide
transitions utilized a Thr intermediate.
The case for a true catalytic tetrad, at least in clan PA, now seems
weaker than originally suggested by sequence data (2). Among
chymotrypsin-like proteases, Ser214 appears to have been
conserved because of its role in substrate recognition, ensuring
optimal diffusion into the active site and proper induced fit
rearrangement of the enzyme-substrate complex. Upon first glance, this
function may not seem as crucial as that performed by the catalytic
nucleophile Ser195, but Ser214 is conserved
almost as strongly as Ser195, highlighting the evolutionary
and physiologic importance of tight substrate binding (21) in the vast
majority of serine proteases.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Research Grants HL49413 and HL58141.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biophysics, Washington University School of Medicine, Box
8231, St. Louis, MO 63110. Tel.: 314-362-4185; Fax: 314-747-5354;
E-mail: enrico@biochem.wustl.edu.
Published, JBC Papers in Press, August 13, 2002, DOI 10.1074/jbc.M206173200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MES, 2-(N-morpholino)ethanesulfonic acid; ChCl, choline chloride; FPR, H-D-Phe-Pro-Arg-p-nitroanilide; PEG, polyethylene glycol; PAR, protease-activated receptor.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Barrett, A. J., and Rawlings, R. D. (1995) Arch. Biochem. Biophys. 318, 247-250[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Krem, M. M., and Di Cera, E. (2001) EMBO J. 20, 3036-3045[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Krem, M. M., and Di Cera, E. (2002) Trends Biochem. Sci. 26, 67-74 |
| 4. | Perona, J. J., and Craik, C. S. (1995) Protein Sci. 4, 337-360[Abstract] |
| 5. | McGrath, M. E., Vasquez, J. R., Craik, C. S., Yang, A. S., Honig, B., and Fletterick, R. J. (1992) Biochemistry 31, 3059-3064[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Pletnev, V. Z., Zamolodchikova, T. S., Pangborn, W. A., and Duax, W. L. (2000) Proteins 41, 8-16[Medline] [Order article via Infotrieve] |
| 7. | Siezen, R. J., and Leunissen, J. A. M. (1997) Protein Sci. 6, 501-523[Abstract] |
| 8. | Rudenko, G., Bonten, E., d'Azzo, A., and Hol, W. G. J. (1995) Structure 3, 1249-1259[Medline] [Order article via Infotrieve] |
| 9. | Shilton, B. H., Thomas, D. Y., and Cygler, M. (1997) Biochemistry 36, 9002-9012[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Ayala, Y. M., and Di Cera, E. (2000) Protein. Sci. 9, 1589-1593[Abstract] |
| 11. | Dang, Q. D., Guinto, E. R., and Di Cera, E. (1997) Nat. Biotechnol. 15, 146-149[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Ayala, Y. M., Cantwell, A. M., Rose, T., Bush, L. A., Arosio, D., and Di Cera, E. (2001) Proteins 45, 107-116[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Rezaie, A. R. (1998) Protein Sci. 7, 349-357[Abstract] |
| 14. | Epstein, D. M., and Abeles, R. H. (1992) Biochemistry 31, 11216-11223[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Di Cera, E.,
Guinto, E. R.,
Vindigni, A.,
Dang, Q. D.,
Ayala, Y. M.,
Wuyi, M.,
and Tulinsky, A.
(1995)
J. Biol. Chem.
270,
22089-22092 |
| 16. |
Pineda, A. O.,
Savvides, S. N.,
Waksman, G.,
and Di Cera, E.
(2002)
J. Biol. Chem.
277,
40177-40180 |
| 17. | Guinto, E. R., and Di Cera, E. (1997) Biophys. Chem. 64, 103-109[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Arosio, D., Ayala, Y. M., and Di Cera, E. (2000) Biochemistry 39, 8095-8101[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Guinto, E. R.,
Caccia, S.,
Rose, T.,
Fütterer, K.,
Waksman, G.,
and Di Cera, E.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1852-1857 |
| 20. |
Kim, S.,
Narayana, S. V. L.,
and Volanakis, J. E.
(1995)
J. Biol. Chem.
270,
24399-24405 |
| 21. |
Rose, T.,
and Di Cera, E.
(2002)
J. Biol. Chem.
277,
19243-19246 |
This article has been cited by other articles:
![]() |
A. Hidalgo, A. Schliessmann, R. Molina, J. Hermoso, and U. T. Bornscheuer A one-pot, simple methodology for cassette randomisation and recombination for focused directed evolution Protein Eng. Des. Sel., June 17, 2008; (2008) gzn034v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bah, L. C. Garvey, J. Ge, and E. Di Cera Rapid Kinetics of Na+ Binding to Thrombin J. Biol. Chem., December 29, 2006; 281(52): 40049 - 40056. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Pineda, Z.-W. Chen, A. Bah, L. C. Garvey, F. S. Mathews, and E. Di Cera Crystal Structure of Thrombin in a Self-inhibited Conformation J. Biol. Chem., October 27, 2006; 281(43): 32922 - 32928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Page and E. Di Cera Role of na+ and k+ in enzyme function. Physiol Rev, October 1, 2006; 86(4): 1049 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, G. Yang, Y. Liu, and Y. Feng Discrimination of Esterase and Peptidase Activities of Acylaminoacyl Peptidase from Hyperthermophilic Aeropyrum pernix K1 by a Single Mutation J. Biol. Chem., July 7, 2006; 281(27): 18618 - 18625. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Mengwasser, L. A. Bush, P. Shih, A. M. Cantwell, and E. Di Cera Hirudin Binding Reveals Key Determinants of Thrombin Allostery J. Biol. Chem., July 22, 2005; 280(29): 26997 - 27003. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Bobofchak, A. O. Pineda, F. S. Mathews, and E. Di Cera Energetic and Structural Consequences of Perturbing Gly-193 in the Oxyanion Hole of Serine Proteases J. Biol. Chem., July 8, 2005; 280(27): 25644 - 25650. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, L. A. Bush, A. O. Pineda, S. Caccia, and E. Di Cera Thrombomodulin Changes the Molecular Surface of Interaction and the Rate of Complex Formation between Thrombin and Protein C J. Biol. Chem., March 4, 2005; 280(9): 7956 - 7961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Pineda, C. J. Carrell, L. A. Bush, S. Prasad, S. Caccia, Z.-W. Chen, F. S. Mathews, and E. Di Cera Molecular Dissection of Na+ Binding to Thrombin J. Biol. Chem., July 23, 2004; 279(30): 31842 - 31853. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Pineda, S. N. Savvides, G. Waksman, and E. Di Cera Crystal Structure of the Anticoagulant Slow Form of Thrombin J. Biol. Chem., October 18, 2002; 277(43): 40177 - 40180. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | F |